Login to Your Account



PDL Enters Eos Buyout Deal To Gain Platform, Early Drugs

By Randall Osborne


Thursday, February 6, 2003
A year after shareholders of a different firm put the kibosh on a planned merger with privately held Eos Biotechnology Inc., Protein Design Labs Inc. said it has entered an agreement to pay $37.5 million for the spurned company. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription